Use of a compound for the treatment of schizophrenia

Details Use of a compound for the treatment of schizophrenia Use of a compound for the treatment of schizophrenia

1988-08-22

1989-11-21

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31425

Patent

active

048823457

ABSTRACT:
2-amino-6-(trifluoromethoxy)benzothiazole or a pharmaceutically accpetable salt thereof is useful for the treatment of schizophrenia, particularly the negative forms thereof.

REFERENCES:
patent: 4370338 (1983-01-01), Mizoule
Arthur Rifkin, Drug Treatment of Acute Schizophrenia, 1095-1099.
John M. Kane, Maintenance Pharmacotherapy in Schizophrenia, 1103-1109.
Goodman and Gilman's, The Pharmacological Basis of Therapeutics Cover Sheet.
Ross J. Baldessarini, Drugs and the Treatment of Psychiactric Disorders 387.
Stewart C. Harvey, Hypnotics and Sedatives, 339-340.
Nancy C. Andreasen, Negative Symptoms in Schizophrenia 744-788.
William T. Carpenter, Jr. Deficit and Nondeficit Forms of Schizophrenia: The Concept.

Affiliated with

Also associated with

Rating

Use of a compound for the treatment of schizophrenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a compound for the treatment of schizophrenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a compound for the treatment of schizophrenia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1426317